This article is based on independent Parkinson's research conducted with the Vielight Neuro Gamma by the University of Sydney Vielight Neuro Gamma Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, located in the midbrain section, which controls movement. This leads [...]
Vielight featured in USA Today for Alzheimer's and Parkinsons' Research! We were recently featured in USA Today! This independent article covers the modern day challenges that humanity faces and how our Vielight Neuro is being used in cutting-edge photobiomodulation research to study the effects of optimized, high-powered NIR energy delivery to the brain. This [...]
This study was a historical first in showing the potential efficacy of photobiomodulation for Parkinson's symptoms in humans. The Vielight Neuro Gamma was utilized for transcranial-intranasal brain photobiomodulation and an Irradia MID 2.5 laser device for neck and abdominal photobiomodulation throughout this study. Read the full study here: Link Watch the explainer video below. [...]
